Možnosti predikce efektu léčby EGFR tyrozinkinázovými inhibitory u pacientů s pokročilým nemalobuněčným karcinomem plic
Introduction: Targeted therapy with low molecular-weight tyrosine kinase inhibitors (TKI) directed at inhibition of epidermal growth factor receptor (EGFR) is a novel effective option for systemic treatment of locally-advanced or metastatic non-small cell lung cancer (NSCLC). Finding biomarkers that...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Doctoral Thesis |
| Language: | Czech |
| Published: |
2014
|
| Online Access: | http://www.nusl.cz/ntk/nusl-342344 |